NCT05176483 · Interventional trial
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Overall registry status Recruiting
Phase 1
Conditions Clear Cell Renal Cell Carcinoma (ccRCC), Colorectal Cancer (CRC), Drug-Drug Interaction (DDI), Head and Neck Squamous Cell Carcinoma (HNSCC), Hepatocellular Carcinoma (HCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Non-Clear Cell Renal Cell Carcinoma (nccRCC), Non-small Cell Lung Cancer (NSCLC), Renal Cell Carcinoma (RCC), Solid Tumor, Urothelial Carcinoma (UC)
Delaware Valley sites
- Exelixis Clinical Site #98 · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory